Beneficial owner of MoonLake Immunotherapeutics Bihua Chen purchased 293,212 shares of the stock at $57.30 per share between October 2 and October 4, for a total transaction amount of $16,800,344.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on MLTX:
- MoonLake Immunotherapeutics to present Phase 2 MIRA trial data for sonelokimab
- Phase 2 MIRA primary analysis trial results (12-week) for MoonLake’s Nanobody® sonelokimab in hidradenitis suppurativa to be presented at a late-breaking session at the European Academy of Dermatology and Venereology Congress
- MoonLake Immunotherapeutics downgraded to Neutral from Buy at Bryan Garnier
- Scinai Immunotherapeutics announces results from preclinical NanoAbs study
- MoonLake faces less competition after Acelyrin failure, says Guggenheim
Questions or Comments about the article? Write to editor@tipranks.com